Willow Biosciences Enters Multi Year CBG Supply Deal
Willow Biosciences (TSX: WLLW) this morning announced its first multi-year supply agreement. The company is set to provide Cellular Goods
Read moreWillow Biosciences (TSX: WLLW) this morning announced its first multi-year supply agreement. The company is set to provide Cellular Goods
Read moreWillow Biosciences (TSX: WLLW) appears to be backing up its proprietary IP with clinical trials. The company this morning announced
Read moreToday on the Daily Dive, we sit down with that of Trevor Peters, CEO of Willow Biosciences (TSX: WLLW). Trevor
Read moreCannabinoids have officially been produced at commercial scale via fermentation. The landmark announcement was made by Willow Biosciences (TSX: WLLW)
Read moreWillow Biosciences (TSX: WLLW) this morning provided an update on its acceleration of outstanding common share purchase warrants. The company
Read moreWillow Biosciences Inc. (TSX: WLLW) is a small-cap biotechnology company that produces high-purity, pharmaceutical-grade, plant-derived compounds that are the building blocks
Read moreWillow Biosciences (TSX: WLLW) on Friday closed their previously announced bought deal financing. The company raised a total of $28.8
Read moreLast week’s announcement that Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has agreed to buy GW Pharmaceuticals (NASDAQ: GWPH) for US$7.2 billion
Read moreLate last night, Willow Biosciences (TSX: WLLW) announced the upsizing of its bought deal financing following strong demand. The company
Read moreWillow Biosciences (TSX: WLLW) this evening announced that it will be conducting a bought deal financing. Lead by Eight Capital
Read more